CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...

DNA commodification is no longer a future concern; it’s a present reality. Beyond charging users for their services, some ...

GeneDx Holdings (NASDAQ:WGS) stock is trading higher on Tuesday. The genetic testing company reported a third-quarter EPS ...

With Ambry Genetics in tow, Eric Lefkofsky's biotech startup hopes to accelerate its drive toward turning a profit.

The global market for cancer-focused genetic testing services is on a transformative growth trajectory, with projections estimating a market size of USD 8,472.70 million by 2024, and an expected ...

Myriad Genetics said it is in talks with UnitedHealthcare to ensure that enrollees continue to have access to its GeneSight mental health medication test after the insurer changed its coverage policy.

Global Cardiovascular Genetic Testing Market is valued at approximately USD 9.07 billion in 2023 and is ... The region’s market is also driven by the growing number of retail pharmacies and improving ...

Unlike medical providers, genetic testing companies aren’t bound by health privacy laws such as HIPAA despite the health information DNA contains. Even if these companies ostensibly promise to ...

These findings demonstrate disparities in precise genetic diagnosis are not due to diagnostic yields ... GeneDx is at the ...

A simple saliva test showed 30-year-old Georgie Bellette has a high risk of developing cancer.Although the news was a shock, ...